128 related articles for article (PubMed ID: 36716688)
1. Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma.
Moon S; Kim HJ; Lee Y; Lee YJ; Jung S; Lee JS; Hahn SH; Kim K; Roh JY; Nam S
Comput Biol Med; 2023 Mar; 154():106602. PubMed ID: 36716688
[TBL] [Abstract][Full Text] [Related]
2. Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals.
Chiu YJ; Li CY; Wang TH; Ma H; Chou TY
J Dermatol; 2024 May; 51(5):659-670. PubMed ID: 38469735
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in primary melanoma in Taiwan.
Sheen YS; Tan KT; Tse KP; Liao YH; Lin MH; Chen JS; Liau JY; Tseng YJ; Lee CH; Hong CH; Liao JB; Chang HT; Chu CY
Br J Dermatol; 2020 May; 182(5):1205-1213. PubMed ID: 31408190
[TBL] [Abstract][Full Text] [Related]
4. Mutational profiling of acral melanomas in Korean populations.
Shim JH; Shin HT; Park J; Park JH; Lee JH; Yang JM; Kim DH; Jang KT; Lee DY
Exp Dermatol; 2017 Oct; 26(10):883-888. PubMed ID: 28191690
[TBL] [Abstract][Full Text] [Related]
5. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
Moon KR; Choi YD; Kim JM; Jin S; Shin MH; Shim HJ; Lee JB; Yun SJ
J Invest Dermatol; 2018 Apr; 138(4):933-945. PubMed ID: 29191620
[TBL] [Abstract][Full Text] [Related]
6. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of genomic alterations in acral melanoma.
Broit N; Johansson PA; Rodgers CB; Walpole ST; Hayward NK; Pritchard AL
Pigment Cell Melanoma Res; 2022 May; 35(3):369-386. PubMed ID: 35229492
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract][Full Text] [Related]
9. Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway.
Mao L; Dai J; Cao Y; Bai X; Sheng X; Chi Z; Cui C; Kong Y; Zhang Y; Wu L; Wang X; Tang B; Lian B; Yan X; Li S; Zhou L; Wei X; Li C; Qi Z; Si L; Guo J
Eur J Cancer; 2021 May; 148():297-306. PubMed ID: 33770575
[TBL] [Abstract][Full Text] [Related]
10. Identification of genetic mutations related to invasion and metastasis of acral melanoma via whole-exome sequencing.
Lim Y; Lee DY
J Dermatol; 2021 Jul; 48(7):999-1006. PubMed ID: 33890690
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract][Full Text] [Related]
12. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
[TBL] [Abstract][Full Text] [Related]
13. Genomic Landscapes of Acral Melanomas in East Asia.
Chang JW; Hsieh JJ; Wu CE; Lim AH; Ng CC; Teh BT; Chan JY
Cancer Genomics Proteomics; 2021; 18(1):83-92. PubMed ID: 33419898
[TBL] [Abstract][Full Text] [Related]
14. Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.
Kong Y; Sheng X; Wu X; Yan J; Ma M; Yu J; Si L; Chi Z; Cui C; Dai J; Li Y; Yu H; Xu T; Tang H; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Guo J
Clin Cancer Res; 2017 Nov; 23(22):6946-6957. PubMed ID: 28830923
[No Abstract] [Full Text] [Related]
15. Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology.
Desai A; Ugorji R; Khachemoune A
Clin Exp Dermatol; 2017 Dec; 42(8):845-848. PubMed ID: 28940724
[TBL] [Abstract][Full Text] [Related]
16. Targeted sequencing of localized acral melanoma in Korean patients identified recurrent CCND1 amplification.
Kim YS; Jung SH; Chung YJ; Lee JH
Int J Dermatol; 2022 Feb; 61(2):e61-e63. PubMed ID: 34242401
[No Abstract] [Full Text] [Related]
17. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
Gui J; Guo Z; Wu D
J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.
Han A; Schug ZT; Aplin AE
Trends Cancer; 2021 Aug; 7(8):671-681. PubMed ID: 34127435
[TBL] [Abstract][Full Text] [Related]
19. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
[TBL] [Abstract][Full Text] [Related]
20. Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
Niu HT; Zhou QM; Wang F; Shao Q; Guan YX; Wen XZ; Chen LZ; Feng QS; Li W; Zeng YX; Zhang XS
Pigment Cell Melanoma Res; 2013 Sep; 26(5):646-53. PubMed ID: 23751074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]